The medication is suitable for patients who are not currently treated with metformin as well as those who are already taking metformin
Nicholls SJ, Tofe S, le Roux CW, DAlessio DA, Wiese RJ, Pavo I, Brown K, Weerakkody GJ, Zeytinoglu M, Romera IC
ADIS DRUG PROFILE , (2005)
Common side effects include: Injection Site Reactions: Soreness, redness, or swelling at the injection site can occur
The compound's design as a competitive inhibitor fused with HIV-TAT for cellular uptake represents advanced peptide engineering that enables intracellular delivery and specific protein-protein interaction disruption, providing researchers with tools for studying senescence mechanisms that were previously inaccessible
TABLE 2 Statistics of gene therapy and RNA interventions to elevate GPX4 or inhibit promoters for OA treatment